Nurix Therapeutics, Inc.

ROYAL BANK OF CANADA NRIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

10,842

Value ($000)

206

Weight

0.0%

2020 Q3 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	206	0.0%	10,842	12/31/2025
2025 Q2	8/14/2025	1,290	0.0%	113,233	6/30/2025
2025 Q1	11/21/2025	81	0.0%	6,815	3/31/2025
2024 Q4	2/14/2025	334	0.0%	17,753	12/31/2024
2024 Q3	11/14/2024	973	0.0%	43,248	9/30/2024
2024 Q2	11/6/2024	121	0.0%	5,790	6/30/2024
2024 Q1	11/5/2024	17	0.0%	1,164	3/31/2024
2023 Q4	2/14/2024	154	0.0%	14,923	12/31/2023
2023 Q3	11/14/2023	64	0.0%	8,107	9/30/2023
2023 Q2	8/14/2023	58	0.0%	5,804	6/30/2023
2023 Q1	5/15/2023	24	0.0%	2,726	3/31/2023
2022 Q4	2/14/2023	77	0.0%	7,083	12/31/2022
2022 Q3	11/14/2022	10	0.0%	773	9/30/2022
2022 Q2	8/15/2022	4	0.0%	353	6/30/2022
2022 Q1	5/16/2022	28	0.0%	2,027	3/31/2022
2021 Q4	2/14/2022	205	0.0%	7,095	12/31/2021
2021 Q3	11/15/2021	9	0.0%	309	9/30/2021
2021 Q2	8/16/2021	4	0.0%	146	6/30/2021
2021 Q1	7/20/2021	68	0.0%	2,190	3/31/2021
2020 Q4	2/16/2021	13	0.0%	405	12/31/2020
2020 Q3	11/16/2020	3	0.0%	100	9/30/2020